BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2013
View Archived Issues
The discovery and characterization of a first-in-class agent against tuberculosis
Read More
Novel lung cancer vaccine CV-9202 evaluated in phase I trial
Read More
Phase I study of AG-221 commences in advanced hematological malignancies
Read More
The identification of novel genetic mutations in children with epilepsy
Read More
New aminoglycoside antibiotic for Gram-negative infections
Read More
BTK inhibitors described by Beta Pharma
Read More
New antiarrythmics reported by Sanofi
Read More
Pfizer discloses novel sodium channel blockers for pain
Read More
Successful generation of clinical-grade iPSCs from research-grade cells
Read More
The discovery and validation of a topical solution to improve allogeneic corneal graft survival
Read More
Sera Prognostics' PAPR study of PreTRM preterm birth test reaches full enrollment
Read More
UK DFID supports Drugs for Neglected Diseases initiative
Read More
HypoThermosol used in two Intercytex trials of cell-based wound care
Read More
Preclinical toxicology study of intravenous PG-545 completed
Read More
FDA accepts Pennsaid 2% NDA for review
Read More
Sobi seeks European approval for Orfadin oral suspension
Read More
Plethora and Shionogi expand agreement for PSD-502
Read More
Chugai Pharmaceutical seeks additional formulation approval for Cellcept
Read More
Galapagos divulges new series of tyrosine-protein kinase inhibitors
Read More
Astellas launches Astagraf XL in U.S. for prophylaxis of organ rejection after kidney transplant
Read More
Boehringer Ingelheim to launch Gilotrif tablets in the U.S. in early September
Read More
Shire and Santaris extend partnership to develop drugs for rare genetic diseases
Read More
C3 Jian completes phase I trial of therapeutic for prevention of tooth decay
Read More
EnteraGam launched for the dietary management of IBS-D
Read More